Literature DB >> 1251716

Administration of interferon to an infant with congenital rubella syndrome involving persistent viremia and cutaneous vasculitis.

A Larsson, M Forsgren, S Hård af Segerstad, H Strander, K Cantell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1251716     DOI： 10.1111/j.1651-2227.1976.tb04415.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN： 0001-656X


× No keyword cloud information.
  6 in total

1.  Late-onset rubella syndrome: coexistence of immune complex disease and defective cytotoxic effector cell function.

Authors:  H Verder; E Dickmeiss; S Haahr; E Kappelgaard; J Leerbøy; A Møller-Larsen; H Nielsen; P Platz; C Koch
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

Review 2.  Interferon: therapeutic fact or fiction for the '80s?

Authors:  G M Scott; D A Tyrrell
Journal:  Br Med J       Date:  1980-06-28

Review 3.  Interferons and interferon inducers: development of clinical usefulness and therapeutic promise.

Authors:  R B Pollard
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

4.  Aging in vitro and large-scale interferon production by 15 new strains of human diploid fibroblasts.

Authors:  J S Horoszewicz; S S Leong; M Ito; L Di Berardino; W A Carter
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

5.  Interferon production: variation in yields from human cell lines.

Authors:  A Meager; H E Graves; J Shuttleworth; N Zucker
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

6.  Alpha interferon administration to infants with congenital rubella.

Authors:  A M Arvin; N J Schmidt; K Cantell; T C Merigan
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.